« ACS Med Chem Letters |
| Dundee's NMT Inhibitors for Sleeping Sickness: An Update »
April 9, 2010
Patent Chart Update
I had some correspondence with the people at MassHighTech about their "New England Patent Rankings" chart (which I spoke about here). That's the one that shows Pfizer with only three patents in 2009, which didn't make a whole lot of sense, considering the size of the operation in Groton/New London.
A look through the patent databases (which several readers also confirmed) showed that something was apparently off, since there were numerous Pfizer patents where the inventors all were from Connecticut. But as it turns out, the MassHighTech people say that their consultant looks at the states of the assignees, and filters out any that don't contain CT, VT, ME, NH, MA, or RI. So that means that many Pfizer patents, which are assigned to the company at its global HQ in New York, don't make the cut.
That seems like an odd way to do things, but maybe it's just me. The people at MassHighTech say that they're looking specifically for "New England-based companies" on their list, but in that case, you wonder how even three Pfizer patents made it in.
+ TrackBacks (0) | Category: Patents and IP
POST A COMMENT
- RELATED ENTRIES
- The Worst Seminar
- Conference in Basel
- Messed-Up Clinical Studies: A First-Hand Report
- Pharma and Ebola
- Lilly Steps In for AstraZeneca's Secretase Inhibitor
- Update on Alnylam (And the Direction of Things to Come)
- There Must Have Been Multiple Chances to Catch This
- Weirdly, Tramadol Is Not a Natural Product After All